Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma

Background: Lung adenocarcinoma (LUAD) is the most common histologic type of non-small cell lung cancer (NSCLC; approximately 60%), and platinum-based chemotherapy is the cornerstone of the treatment for patients with LUAD. However, a considerable number of patients experience tumor recurrence after...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Liu, Junfang, Fang, Zekui, Liang, Zhenyu, Chen, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658917/
https://www.ncbi.nlm.nih.gov/pubmed/33192515
http://dx.doi.org/10.3389/fphar.2020.572627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658917/
https://www.ncbi.nlm.nih.gov/pubmed/33192515
http://dx.doi.org/10.3389/fphar.2020.572627

Ejemplares similares